Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a promising therapeutic agent for the alleviation of various myeloid disorders. Its mechanism of action involves augmenting platelet https://tasneemrwdy664945.wikicommunications.com/user